IA
PTX

Icon Advisers’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Icon Advisers’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,469
Closed -$1.75M – 385
2015
Q2 		$1.75M Buy
29,469
+5,000
+20% +$353K 0.11% 173
2015
Q1 		$2.62M Buy
+24,469
New +$2.33M 0.15% 134

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Icon Advisers's PTX Position: Q3 2015 in Review

Icon Advisers sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 29,469 shares — an estimated $1.75M sold.

Icon Advisers first reported a position in PTX in Q1 2015 and held it in 2 quarters. The position peaked at $2.62M in Q1 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.

  • Icon Advisers reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
  • Icon Advisers sold 29,469 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $1.75M.
  • Icon Advisers first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 2 quarters.
  • Icon Advisers's Pernix Therapeutics Holdings, Inc. position peaked at $2.62M in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.

Based on Icon Advisers's 13F filing for Q3 2015, filed 5 Nov 2015.